JUNS
Jupiter Neurosciences Inc
NASDAQ · Pharmaceuticals
$0.60
-0.02 (-2.65%)
Open$0.60
Previous Close$0.62
Day High$0.61
Day Low$0.57
52W High$54.48
52W Low$31.09
Volume—
Avg Volume568.8K
Market Cap20.64M
P/E Ratio21.39
EPS$1.85
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+7,229.0% upside
Current
$0.60
$0.60
Target
$43.93
$43.93
$31.75
$43.93 avg
$69.04
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.37M | 3.89M | 4.34M |
| Net Income | 924.0K | 896.5K | 1.08M |
| Profit Margin | 21.1% | 23.1% | 24.9% |
| EBITDA | 1.37M | 1.23M | 1.59M |
| Free Cash Flow | 866.3K | 754.2K | 863.0K |
| Rev Growth | +10.8% | +2.3% | +6.5% |
| Debt/Equity | 0.26 | 0.24 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |